Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Audentes

- PMLiVE

Astellas seeks FDA approval for personalised Tarceva in lung cancer

Application supported by Roche's EGFR companion diagnostic test

Janssen adds Astellas JAK inhibitor to its immunology portfolio

Licenses oral rheumatoid arthritis and psoriasis candidate ASP015K

- PMLiVE

Astellas’ Jo Underhill promoted to UK sales and marketing director role

She will head the company’s UK urology and dermatology efforts

- PMLiVE

Astellas Pharma takes on new sales and marketing director

Jo Underhill will head the company’s UK sales and marketing in urology and dermatology 

Astellas wins US approval for prostate cancer drug Xtandi

Pharma company and its partner Medivation gain FDA licence for type of late-stage prostate cancer

- PMLiVE

Astellas Pharma Europe appoint new senior director, market access

Dr Susan Wood was previously senior brand director of the company’s pain management franchise 

Astellas to close US urology research facility

Work at Urogenix, North Carolina site will end by the end of the year

- PMLiVE

Interview: Yoshihiko Hatanaka, CEO and president, Astellas

The president and CEO of Astellas Pharma tells Jacky Law how he intends to steer the company through the current economic downturn

- PMLiVE

Interview: Ken Jones, Astellas Pharma Europe

The president and CEO of Astellas Pharma Europe talks to Liz Wells about beating the economic downturn and the experience of working for a Japanese company

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links